Contraception
Conditions
Keywords
Contraception, Pregnancy Prevention, Digital Health, Pharmacist, Community Pharmacy Services, Patient-reported Outcomes
Brief summary
Hormonal contraceptives are medications that require a prescription, traditionally from a physician or advanced practice provider. Over the past decade, pharmacists have gained the authority to prescribe contraceptives in many states, allowing patients to access these medications directly in pharmacies without first seeing another healthcare provider. The Pharmacist Resource to Implement Services as Modules (PRISM) is an Electronic Health Record platform designed to streamline workflows and provide clinical decision support, making it easier and safer to deliver clinical services in community pharmacies. This pilot study will evaluate patient-reported outcomes for women receiving contraceptive services from pharmacists using the PRISM platform at five community pharmacies across the United States over a 12-week period. The study will assess the quality of care, contraception continuation and failure rates, side effect rates, preventative healthcare utilization, and overall patient experience with pharmacy contraceptive services.
Interventions
An electronic health record (EHR) platform specifically designed to support community pharmacists in delivering contraceptive services. The platform streamlines clinical workflows, provides clinical decision support, and promotes adherence to the US Medical Eligibility Criteria (USMEC) guidelines and state regulatory requirements.
Sponsors
Study design
Eligibility
Inclusion criteria
• Women presenting for hormonal contraceptives
Exclusion criteria
* Age less than 18 years * Pregnancy * Unable to become pregnant * Not English speaking * Suspected coercion * Unable to consent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Person-Centered Contraceptive Counseling (PCCC) Measure | Within 7 days post-intervention | The percentage of patients who report that the pharmacist provided overall patient-centered care, as defined by achieving the highest rating on all four items of the PCCC survey. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Three-month Contraceptive Continuation Rate | Within 97 days post-intervention | The percentage of patients who report continuous use of their selected contraceptive method three months after the pharmacist encounter. Continuous use is defined as using the method at the time of the survey with no gaps in use of one month or longer. |
Countries
United States